217 related articles for article (PubMed ID: 28439654)
1. Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.
Taouli B; Hoshida Y; Kakite S; Chen X; Tan PS; Sun X; Kihira S; Kojima K; Toffanin S; Fiel MI; Hirschfield H; Wagner M; Llovet JM
Eur Radiol; 2017 Nov; 27(11):4472-4481. PubMed ID: 28439654
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomics Associates Molecular Features with
Kwee SA; Tiirikainen M; Sato MM; Acoba JD; Wei R; Jia W; Le Marchand L; Wong LL
Cancer Res; 2019 Apr; 79(7):1696-1704. PubMed ID: 30760520
[TBL] [Abstract][Full Text] [Related]
3. The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.
Ahn SM; Haq F; Park I; Nault JC; Zucman-Rossi J; Yu E
BMC Cancer; 2018 May; 18(1):571. PubMed ID: 29776391
[TBL] [Abstract][Full Text] [Related]
4. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
5. Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging.
Chou CT; Chen RC; Lee CW; Ko CJ; Wu HK; Chen YL
Br J Radiol; 2012 Jun; 85(1014):778-83. PubMed ID: 21828149
[TBL] [Abstract][Full Text] [Related]
6. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
[TBL] [Abstract][Full Text] [Related]
7. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies.
Beaufrère A; Caruso S; Calderaro J; Poté N; Bijot JC; Couchy G; Cauchy F; Vilgrain V; Zucman-Rossi J; Paradis V
J Hepatol; 2022 Feb; 76(2):343-352. PubMed ID: 34624411
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological indices to predict hepatocellular carcinoma molecular classification.
Tan PS; Nakagawa S; Goossens N; Venkatesh A; Huang T; Ward SC; Sun X; Song WM; Koh A; Canasto-Chibuque C; Deshmukh M; Nair V; Mahajan M; Zhang B; Fiel MI; Kobayashi M; Kumada H; Hoshida Y
Liver Int; 2016 Jan; 36(1):108-18. PubMed ID: 26058462
[TBL] [Abstract][Full Text] [Related]
9. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma.
Hectors SJ; Lewis S; Besa C; King MJ; Said D; Putra J; Ward S; Higashi T; Thung S; Yao S; Laface I; Schwartz M; Gnjatic S; Merad M; Hoshida Y; Taouli B
Eur Radiol; 2020 Jul; 30(7):3759-3769. PubMed ID: 32086577
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
11. A novel ferroptosis phenotype-related clinical-molecular prognostic signature for hepatocellular carcinoma.
Deng T; Hu B; Jin C; Tong Y; Zhao J; Shi Z; Zhang T; Deng L; Sun Z; Chen G; Wang Y
J Cell Mol Med; 2021 Jul; 25(14):6618-6633. PubMed ID: 34085405
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis.
Pan Q; Long X; Song L; Zhao D; Li X; Li D; Li M; Zhou J; Tang X; Ren H; Ding K
Oncotarget; 2016 Jun; 7(25):38487-38499. PubMed ID: 27220887
[TBL] [Abstract][Full Text] [Related]
13. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.
Villanueva A; Hoshida Y; Battiston C; Tovar V; Sia D; Alsinet C; Cornella H; Liberzon A; Kobayashi M; Kumada H; Thung SN; Bruix J; Newell P; April C; Fan JB; Roayaie S; Mazzaferro V; Schwartz ME; Llovet JM
Gastroenterology; 2011 May; 140(5):1501-12.e2. PubMed ID: 21320499
[TBL] [Abstract][Full Text] [Related]
14. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
[TBL] [Abstract][Full Text] [Related]
15. Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.
Yoneda N; Matsui O; Kobayashi S; Kitao A; Kozaka K; Inoue D; Yoshida K; Minami T; Koda W; Gabata T
Jpn J Radiol; 2019 Mar; 37(3):191-208. PubMed ID: 30712167
[TBL] [Abstract][Full Text] [Related]
16. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Hoshida Y; Nijman SM; Kobayashi M; Chan JA; Brunet JP; Chiang DY; Villanueva A; Newell P; Ikeda K; Hashimoto M; Watanabe G; Gabriel S; Friedman SL; Kumada H; Llovet JM; Golub TR
Cancer Res; 2009 Sep; 69(18):7385-92. PubMed ID: 19723656
[TBL] [Abstract][Full Text] [Related]
17. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
[TBL] [Abstract][Full Text] [Related]
18. Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma.
Kuo MD; Gollub J; Sirlin CB; Ooi C; Chen X
J Vasc Interv Radiol; 2007 Jul; 18(7):821-31. PubMed ID: 17609439
[TBL] [Abstract][Full Text] [Related]
19. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
20. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
